Chalkidou, Kalipso

A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers

Thorpe, K. E., Zwarenstein, M., Oxman, A. D., Treweek, S., Furberg, C. D., Altman, D. G., Tunis, S., Bergel, E., Harvey, I., Magid, D. J., et al. (2009) · Journal of Clinical Epidemiology

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 1,389

NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4

Bennett, J. E., Stevens, G. A., Mathers, C. D., Bonita, R., Rehm, J., Kruk, M. E., Riley, L. M., Dain, K., Kengne, A. P., Chalkidou, K., et al. (2018) · The Lancet

Global Public Health Policies and EpidemiologyHealthcare Systems and Public Health

Cited by 1,336

NCD Countdown 2030: pathways to achieving Sustainable Development Goal target 3.4

Bennett, J. E., Kontis, V., Mathers, C. D., Guillot, M., Rehm, J., Chalkidou, K., Kengne, A. P., Carrillo-Larco, R. M., Bawah, A. A., Dain, K., et al. (2020) · The Lancet

Healthcare Systems and Public HealthGlobal Public Health Policies and Epidemiology

Cited by 447

How to formulate research recommendations

Brown, P., Brunnhuber, K., Chalkidou, K., Chalmers, I., Clarke, M., Fenton, M., Forbes, C., Glanville, J., Hicks, N. J., Moody, J., et al. (2006) · BMJ

Glioma Diagnosis and TreatmentProtein Kinase Regulation and GTPase Signaling

Cited by 381

The use of cost-effectiveness thresholds for evaluating health interventions in low- and middle-income countries from 2015 to 2020: a review

Kazibwe, J., Gheorghe, A., Wilson, D., Ruiz, F., Chalkidou, K., & Chi, Y.-L. (2022) · Value in Health

Health Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and Policy

Cited by 139

On results reporting and evidentiary standards: spotlight on the Global Fund

Friebel, R., Silverman, R., Glassman, A., & Chalkidou, K. (2019) · The Lancet

International Development and AidEvaluation and Performance Assessment

Cited by 26